| Year |
Citation |
Score |
| 2021 |
Simpson CL, Mosier JA, Vyavahare NR. Osteoclast-Mediated Cell Therapy as an Attempt to Treat Elastin Specific Vascular Calcification. Molecules (Basel, Switzerland). 26. PMID 34203711 DOI: 10.3390/molecules26123643 |
0.638 |
|
| 2017 |
Tam H, Zhang W, Infante D, Parchment N, Sacks M, Vyavahare N. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties. Journal of Cardiovascular Translational Research. PMID 28213846 DOI: 10.1007/S12265-017-9733-5 |
0.385 |
|
| 2016 |
Nosoudi N, Chowdhury A, Siclari S, Karamched S, Parasaram V, Parrish J, Gerard P, Vyavahare N. Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles. Theranostics. 6: 1975-1987. PMID 27698934 DOI: 10.7150/Thno.16547 |
0.384 |
|
| 2015 |
Nosoudi N, Nahar-Gohad P, Sinha A, Chowdhury A, Gerard P, Carsten CG, Gray BH, Vyavahare NR. Prevention of Abdominal Aortic Aneurysm Progression by Targeted Inhibition of Matrix Metalloproteinase Activity With Batimastat-Loaded Nanoparticles. Circulation Research. 117: e80-9. PMID 26443597 DOI: 10.1161/Circresaha.115.307207 |
0.494 |
|
| 2015 |
Tam H, Zhang W, Feaver KR, Parchment N, Sacks MS, Vyavahare N. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials. Biomaterials. 66: 83-91. PMID 26196535 DOI: 10.1016/J.Biomaterials.2015.07.011 |
0.422 |
|
| 2015 |
Simmers P, Gishto A, Vyavahare N, Kothapalli CR. Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures. Tissue Engineering. Part A. 21: 1455-70. PMID 25597545 DOI: 10.1089/Ten.Tea.2014.0363 |
0.463 |
|
| 2014 |
Lei Y, Nosoudi N, Vyavahare N. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 79-86. PMID 25285609 DOI: 10.1016/J.Jconrel.2014.09.029 |
0.354 |
|
| 2014 |
Sinha A, Shaporev A, Nosoudi N, Lei Y, Vertegel A, Lessner S, Vyavahare N. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1003-12. PMID 24566276 DOI: 10.1016/J.Nano.2014.02.002 |
0.567 |
|
| 2014 |
Lei Y, Sinha A, Nosoudi N, Grover A, Vyavahare N. Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells. Experimental Cell Research. 323: 198-208. PMID 24447384 DOI: 10.1016/J.Yexcr.2014.01.011 |
0.609 |
|
| 2014 |
Sinha A, Nosoudi N, Vyavahare N. Elasto-regenerative properties of polyphenols. Biochemical and Biophysical Research Communications. 444: 205-11. PMID 24440697 DOI: 10.1016/J.Bbrc.2014.01.027 |
0.541 |
|
| 2014 |
Tripi DR, Vyavahare NR. Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves Journal of Biomaterials Applications. 28: 757-766. PMID 24371208 DOI: 10.1177/0885328213479047 |
0.397 |
|
| 2013 |
Lei Y, Grover A, Sinha A, Vyavahare N. Efficacy of reversal of aortic calcification by chelating agents. Calcified Tissue International. 93: 426-35. PMID 23963635 DOI: 10.1007/S00223-013-9780-0 |
0.627 |
|
| 2013 |
Sinha A, Vyavahare NR. High-glucose levels and elastin degradation products accelerate osteogenesis in vascular smooth muscle cells. Diabetes & Vascular Disease Research. 10: 410-9. PMID 23754846 DOI: 10.1177/1479164113485101 |
0.466 |
|
| 2013 |
Eckert CE, Fan R, Mikulis B, Barron M, Carruthers CA, Friebe VM, Vyavahare NR, Sacks MS. On the biomechanical role of glycosaminoglycans in the aortic heart valve leaflet. Acta Biomaterialia. 9: 4653-60. PMID 23036945 DOI: 10.1016/J.Actbio.2012.09.031 |
0.303 |
|
| 2013 |
Leong J, Munnelly A, Liberio B, Cochrane L, Vyavahare N. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. Journal of Biomaterials Applications. 27: 948-60. PMID 22207605 DOI: 10.1177/0885328211430542 |
0.396 |
|
| 2012 |
Munnelly AE, Cochrane L, Leong J, Vyavahare NR. Porcine vena cava as an alternative to bovine pericardium in bioprosthetic percutaneous heart valves. Biomaterials. 33: 1-8. PMID 21993239 DOI: 10.1016/j.biomaterials.2011.09.027 |
0.43 |
|
| 2012 |
Munnelly A, Schoen F, Vyavahare N. Biomaterial calcification: Mechanisms and prevention Degradation of Implant Materials. 359-392. DOI: 10.1007/978-1-4614-3942-4_14 |
0.313 |
|
| 2011 |
Friebe VM, Mikulis B, Kole S, Ruffing CS, Sacks MS, Vyavahare NR. Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 99: 217-29. PMID 21714085 DOI: 10.1002/Jbm.B.31889 |
0.454 |
|
| 2011 |
Kurane A, Vyavahare N. Endothelial cells seeded on elastin-heparin matrices express normal EC markers and resist detachment on exposure to shear stress: A histological study Journal of Histotechnology. 34: 11-19. DOI: 10.1179/014788811X12949268296004 |
0.76 |
|
| 2010 |
Raghavan D, Shah SR, Vyavahare NR. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 92: 168-77. PMID 19810110 DOI: 10.1002/Jbm.B.31503 |
0.587 |
|
| 2009 |
Kurane A, Vyavahare N. In vivo vascular tissue engineering: influence of cytokine and implant location on tissue specific cellular recruitment. Journal of Tissue Engineering and Regenerative Medicine. 3: 280-9. PMID 19283727 DOI: 10.1002/Term.164 |
0.788 |
|
| 2009 |
Raghavan D, Starcher BC, Vyavahare NR. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. Acta Biomaterialia. 5: 983-92. PMID 19091637 DOI: 10.1016/J.Actbio.2008.11.004 |
0.672 |
|
| 2008 |
Shah SR, Vyavahare NR. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves Biomaterials. 29: 1645-1653. PMID 18199477 DOI: 10.1016/j.biomaterials.2007.12.009 |
0.393 |
|
| 2007 |
Kutty JK, Cho E, Soo Lee J, Vyavahare NR, Webb K. The effect of hyaluronic acid incorporation on fibroblast spreading and proliferation within PEG-diacrylate based semi-interpenetrating networks. Biomaterials. 28: 4928-38. PMID 17720239 DOI: 10.1016/J.Biomaterials.2007.08.007 |
0.305 |
|
| 2007 |
Kurane A, Simionescu DT, Vyavahare NR. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 28: 2830-8. PMID 17368531 DOI: 10.1016/J.Biomaterials.2007.02.031 |
0.78 |
|
| 2007 |
Raghavan D, Simionescu DT, Vyavahare NR. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 28: 2861-8. PMID 17353047 DOI: 10.1016/J.Biomaterials.2007.02.017 |
0.636 |
|
| 2007 |
Simpson CL, Lindley S, Eisenberg C, Basalyga DM, Starcher BC, Simionescu DT, Vyavahare NR. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 16: 29-37. PMID 17218212 DOI: 10.1016/J.Carpath.2006.07.001 |
0.758 |
|
| 2007 |
Sellaro TL, Hildebrand D, Lu Q, Vyavahare N, Scott M, Sacks MS. Effects of collagen fiber orientation on the response of biologically derived soft tissue biomaterials to cyclic loading. Journal of Biomedical Materials Research. Part A. 80: 194-205. PMID 17041913 DOI: 10.1002/Jbm.A.30871 |
0.561 |
|
| 2007 |
Mercuri JJ, Lovekamp JJ, Simionescu DT, Vyavahare NR. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 28: 496-503. PMID 17030363 DOI: 10.1016/J.Biomaterials.2006.09.005 |
0.8 |
|
| 2006 |
Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 27: 3645-51. PMID 16527345 DOI: 10.1016/j.biomaterials.2006.02.016 |
0.314 |
|
| 2006 |
Lee JS, Basalyga DM, Simionescu A, Isenburg JC, Simionescu DT, Vyavahare NR. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. The American Journal of Pathology. 168: 490-8. PMID 16436663 DOI: 10.2353/Ajpath.2006.050338 |
0.783 |
|
| 2006 |
Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 27: 1507-18. PMID 16144707 DOI: 10.1016/J.Biomaterials.2005.08.003 |
0.804 |
|
| 2006 |
Simionescu DT, Lu Q, Song Y, Lee JS, Rosenbalm TN, Kelley C, Vyavahare NR. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 27: 702-13. PMID 16048731 DOI: 10.1016/J.Biomaterials.2005.06.013 |
0.679 |
|
| 2005 |
Lu Q, Simionescu A, Vyavahare N. Novel capillary channel fiber scaffolds for guided tissue engineering. Acta Biomaterialia. 1: 607-14. PMID 16701841 DOI: 10.1016/J.Actbio.2005.07.001 |
0.617 |
|
| 2005 |
Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochemical and Biophysical Research Communications. 334: 524-32. PMID 16005428 DOI: 10.1016/J.Bbrc.2005.06.119 |
0.385 |
|
| 2005 |
Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, Kronsteiner A, Defelice S, Xu J, Ohri R, Narula N, Vyavahare N, Levy RJ. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. The American Journal of Pathology. 166: 1-13. PMID 15631995 DOI: 10.1016/S0002-9440(10)62227-4 |
0.507 |
|
| 2005 |
Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 26: 1237-45. PMID 15475053 DOI: 10.1016/j.biomaterials.2004.04.034 |
0.42 |
|
| 2004 |
Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 110: 3480-7. PMID 15545515 DOI: 10.1161/01.Cir.0000148367.08413.E9 |
0.781 |
|
| 2004 |
Sun W, Sacks M, Fulchiero G, Lovekamp J, Vyavahare N, Scott M. Response of heterograft heart valve biomaterials to moderate cyclic loading Journal of Biomedical Materials Research - Part A. 69: 658-669. PMID 15162408 DOI: 10.1002/Jbm.A.30031 |
0.771 |
|
| 2004 |
Lu Q, Ganesan K, Simionescu DT, Vyavahare NR. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials. 25: 5227-37. PMID 15110474 DOI: 10.1016/J.Biomaterials.2003.12.019 |
0.663 |
|
| 2004 |
Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 13: 146-55. PMID 15081471 DOI: 10.1016/S1054-8807(04)00009-2 |
0.437 |
|
| 2004 |
Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials. 25: 3293-302. PMID 14980424 DOI: 10.1016/j.biomaterials.2003.10.001 |
0.406 |
|
| 2003 |
Simionescu DT, Lovekamp JJ, Vyavahare NR. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. Journal of Biomedical Materials Research. Part A. 66: 755-63. PMID 12926026 DOI: 10.1002/Jbm.A.10066 |
0.81 |
|
| 2003 |
Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves Journal of Biomedical Materials Research - Part A. 66: 93-102. PMID 12833435 |
0.413 |
|
| 2003 |
Simionescu DT, Lovekamp JJ, Vyavahare NR. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. The Journal of Heart Valve Disease. 12: 226-34. PMID 12701796 |
0.812 |
|
| 2003 |
Simionescu DT, Lovekamp JJ, Vyavahare NR. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. The Journal of Heart Valve Disease. 12: 217-25. PMID 12701795 |
0.793 |
|
| 2003 |
Levy RJ, Vyavahare N, Ogle M, Ashworth P, Bianco R, Schoen FJ. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. The Journal of Heart Valve Disease. 12: 209-16; discussion 2. PMID 12701794 |
0.345 |
|
| 2003 |
Caldwell RA, Vyavahare N, Langan EM, LaBerge M. Matrix metalloproteinase inhibitor within an absorbable coating for vascular applications: Delivery device characterization and the reduction of smooth muscle cell proliferation and migration Journal of Biomedical Materials Research - Part A. 67: 1-10. DOI: 10.1002/Jbm.A.10046 |
0.351 |
|
| 2001 |
Bailey M, Xiao H, Ogle M, Vyavahare N. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification American Journal of Pathology. 159: 1981-1986. PMID 11733347 |
0.361 |
|
| 2001 |
Alferiev I, Vyavahare N, Song C, Connolly J, Travis Hinson J, Lu Z, Tallapragada S, Bianco R, Levy R. Bisphosphonate derivatized polyurethanes resist calcification Biomaterials. 22: 2683-2693. PMID 11519788 DOI: 10.1016/S0142-9612(01)00010-2 |
0.407 |
|
| 2001 |
Lovekamp J, Vyavahare N. Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves Journal of Biomedical Materials Research. 56: 478-486. PMID 11400125 DOI: 10.1002/1097-4636(20010915)56:4<478::Aid-Jbm1119>3.0.Co;2-C |
0.801 |
|
| 2000 |
Vyavahare N, Jones PL, Tallapragada S, Levy RJ. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats American Journal of Pathology. 157: 885-893. PMID 10980128 DOI: 10.1016/S0002-9440(10)64602-0 |
0.445 |
|
| 2000 |
Lovekamp J, Vyavahare N. Improved extracellular matrix stabilization of bioprosthetic heart valves Annals of Biomedical Engineering. 28: S-4. |
0.383 |
|
| 1999 |
Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Elastin calcification and its prevention with aluminum chloride pretreatment American Journal of Pathology. 155: 973-982. PMID 10487855 DOI: 10.1016/S0002-9440(10)65197-8 |
0.356 |
|
| 1999 |
Mohler ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH. Identification and characterization of calcifying valve cells from human and canine aortic valves Journal of Heart Valve Disease. 8: 254-260. PMID 10399657 |
0.357 |
|
| 1999 |
Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M, Levy RJ. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. Journal of Biomedical Materials Research. 46: 44-50. PMID 10357134 DOI: 10.1002/(Sici)1097-4636(199907)46:1<44::Aid-Jbm5>3.0.Co;2-D |
0.465 |
|
| 1999 |
Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Mechanisms of elastin calcification and its prevention with aluminum chloride pretreatment Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 2: 760. |
0.34 |
|
| 1997 |
Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: Efficacy and mechanisms Circulation. 95: 479-488. PMID 9008467 DOI: 10.1161/01.Cir.95.2.479 |
0.404 |
|
| 1997 |
Vyavahare NR, Chen W, Joshi RR, Lee CH, Hirsch D, Levy J, Schoen FJ, Levy RJ. Current progress in anticalcification for bioprosthetic and polymeric heart valves Cardiovascular Pathology. 6: 219-229. DOI: 10.1016/S1054-8807(97)00017-3 |
0.412 |
|
| 1996 |
Levy RJ, Vyavahare N, Joshi R, Chen W, Hirsch D, Levy J, Schoen F. Current progress in anti-calcification and alternative fixation methodology for bioprosthetic valves Cardiovascular Pathology. 5: 291. DOI: 10.1016/1054-8807(96)80371-1 |
0.344 |
|
| 1995 |
Levy RJ, Labhasetwar V, Song C, Lerner E, Chen W, Vyavahare N, Qu X. Polymeric drug delivery systems for treatment of cardiovascular calcification, arrhythmias and restenosis Journal of Controlled Release. 36: 137-147. DOI: 10.1016/0168-3659(95)00045-A |
0.337 |
|
| 1995 |
Vyavahare NR, Qu X, Lee M, Behari P, Schoen FJ, Levy RJ. Synergism of calcium-ethanehydroxybisphosphonate (CaEHBP) and FeC13: controlled release polymers for preventing calcification of bioprosthetic aortic wall Journal of Controlled Release. 34: 97-108. DOI: 10.1016/0168-3659(94)00130-M |
0.316 |
|
| Show low-probability matches. |